- Home
- HSCS vs LABT Comparison
HSCS vs LABT Comparison
Compare HSCS & LABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.82
N/A
Current Price
$0.00
Company Overview
Basic Information| Metric | HSCS | LABT |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | 12 | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 5.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HSCS | LABT |
|---|---|---|
| Price | $1.82 | N/A |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 34.4K | N/A |
| Earning Date | 03-16-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.63 | N/A |
| 52 Week High | $6.47 | N/A |
Technical Indicators
Market Signals| Indicator | HSCS | LABT |
|---|---|---|
| Relative Strength Index (RSI) | 45.25 | N/A |
| Support Level | $1.77 | N/A |
| Resistance Level | $2.18 | N/A |
| Average True Range (ATR) | 0.16 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 25.93 | 0.00 |
Price Performance
Historical Comparison HSCS
LABT
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.